HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES
申请人:PFIZER INC.
公开号:EP1060178B1
公开(公告)日:2003-09-03
US6610707B1
申请人:——
公开号:US6610707B1
公开(公告)日:2003-08-26
Heterocyclic compounds as inhibitors of rotomase enzymes
申请人:Pfizer Inc.
公开号:US06610707B1
公开(公告)日:2003-08-26
Compounds of the formula:
wherein R1, Y, W, A and R2 are as defined above are inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases and nerve damage.